What Defines a Value Stock?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
Below is a list of notable value stocks in the healthcare sector:
- Syros Pharmaceuticals SYRS - P/E: 8.47
- BioNTech BNTX - P/E: 8.44
- Cross Country Healthcare CCRN - P/E: 8.01
- Solid Biosciences SLDB - P/E: 0.09
- Panbela Therapeutics PBLA - P/E: 0.0
Syros Pharmaceuticals has reported Q3 earnings per share at $-1.43, which has decreased by 10.0% compared to Q2, which was -1.3. BioNTech's earnings per share for Q3 sits at $0.73, whereas in Q2, they were at -0.86. Cross Country Healthcare's earnings per share for Q3 sits at $0.39, whereas in Q2, they were at 0.69. Solid Biosciences has reported Q3 earnings per share at $-1.05, which has increased by 16.0% compared to Q2, which was -1.25. Panbela Therapeutics's earnings per share for Q3 sits at $-2.42, whereas in Q2, they were at -7.95.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.